Showing results (311-320 of 384) with videos related to
Sort By:
Pageof 39
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|February 1, 1996
Tenidap, a structurally novel drug for the treatment of arthritis: antiinflammatory and analgesic propertiesP F Moore, D L Larson, I G Otterness, et al.Aesthetic Surgery Journal|October 8, 2019
Comparative Analysis of Cytokines of Tumor Cell Lines, Malignant and Benign Effusions Around Breast ImplantsMarshall E Kadin, John Morgan, Nick Kouttab, et al.Blood|February 15, 1991
Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysisI J Su, H C Hsieh, K H Lin, et al.Medical and Pediatric Oncology|January 1, 1994
Disseminated nonlymphoblastic lymphoma of childhood: a Childrens Cancer Group study, CCG-552J L Finlay, J R Anderson, A J Cecalupo, et al.The Journal of Investigative Dermatology|March 7, 2018
SATB1 Defines a Subtype of Cutaneous CD30<sup>+</sup> Lymphoproliferative Disorders Associated with a T-Helper 17 Cytokine ProfileJingru Sun, Shengguo Yi, Lei Qiu, et al.Frontiers in Public Health|February 26, 2024
An innovative Indigenous-led model for integrated COVID-19 case management in Auckland, New Zealand: lessons from implementationElana Curtis, Belinda Loring, Kadin Latham, et al.Medical and Pediatric Oncology|December 18, 2001
Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer GroupR Sposto, A T Meadows, R R Chilcote, et al.Leukemia|November 12, 2025
The IL-1R and NFKBIZ pathway mediates immunoregulatory responses and immunotherapy efficacy in anaplastic large cell lymphomaWei Wei, Zhihui Song, Yajun Wang, et al.British Journal of Haematology|March 1, 1996
Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID miceA Terenzi, A Bolognesi, L Pasqualucci, et al.Cancer Immunology, Immunotherapy : CII|November 4, 2020
IL-10, IL-13, Eotaxin and IL-10/IL-6 ratio distinguish breast implant-associated anaplastic large-cell lymphoma from all types of benign late seromasArianna Di Napoli, Daniele Greco, Giorgia Scafetta, et al.Pageof 39